Cargando…

Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents

Objective. Increased coagulation activation may contribute to the high incidence of cardiovascular complications observed in obese and type 2 diabetes (T2D) subjects. Although tissue factor (TF), the primary initiator of coagulation is increased in obesity, its expression in adipose tissues and its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jing, Ciaraldi, Theodore P., Samad, Fahumiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377499/ https://www.ncbi.nlm.nih.gov/pubmed/25861467 http://dx.doi.org/10.1155/2015/291209

Ejemplares similares

S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
por: Chakrabarty, Sagarika, et al.
Publicado: (2022)

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial
por: Tres, Glaucia S., et al.
Publicado: (2018)

Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation
por: Badeanlou, Leylla, et al.
Publicado: (2011)

Plasma Periostin Levels Are Increased in Chinese Subjects with Obesity and Type 2 Diabetes and Are Positively Correlated with Glucose and Lipid Parameters
por: Luo, Yuanyuan, et al.
Publicado: (2016)

Adipose tissue from subjects with type 2 diabetes exhibits impaired capillary formation in response to GROα: involvement of MMPs-2 and -9
por: Amir Levy, Yifat, et al.
Publicado: (2022)

Impact of Sleeve Gastrectomy on Weight Loss, Glucose Homeostasis, and Comorbidities in Severely Obese Type 2 Diabetic Subjects
por: Nosso, G., et al.
Publicado: (2011)

Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
por: Shikora, S., et al.
Publicado: (2013)

Myokine Regulation of Insulin Secretion: Impact of Inflammation and Type 2 Diabetes
por: Ryan, Alexander J., et al.
Publicado: (2020)

Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease
por: Wang, Guang, et al.
Publicado: (2008)

Welcome to Adipocyte
por: Samad, Fahumiya
Publicado: (2012)

Antidiabetic Effect of Fenugreek Seed Powder Solution (Trigonella foenum-graecum L.) on Hyperlipidemia in Diabetic Patients
por: Geberemeskel, Genet Alem, et al.
Publicado: (2019)

Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients
por: Guida, Bruna, et al.
Publicado: (2013)

Impact of Orlistat-Induced Weight Loss on Diastolic Function and Heart Rate Variability in Severely Obese Subjects with Diabetes
por: Martin, Julie, et al.
Publicado: (2011)

Platelet Counts and Platelet Activation Markers in Obese Subjects
por: Samocha-Bonet, Dorit, et al.
Publicado: (2008)

How to Estimate Fat Mass in Overweight and Obese Subjects
por: Donini, Lorenzo Maria, et al.
Publicado: (2013)

Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
por: Liu, Xiaojie, et al.
Publicado: (2017)

Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes
por: Tomić, Martina, et al.
Publicado: (2013)

Treadmill Calibration of the Actigraph GT1M in Young-to-Middle-Aged Obese-to-Severely Obese Subjects
por: Aadland, Eivind, et al.
Publicado: (2012)

Screening of Undiagnosed Hypothyroidism in Elderly Persons with Diabetes according to Age-Specific Reference Intervals for Serum Thyroid Stimulating Hormone and the Impact of Antidiabetes Drugs
por: Fontes, Rosita, et al.
Publicado: (2016)

Health-Related Quality of Life and Quality of Sexual Life in Obese Subjects
por: Poggiogalle, Eleonora, et al.
Publicado: (2014)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes
por: Xu, Yang, et al.
Publicado: (2018)

Serum IL-12 Is Increased in Mexican Obese Subjects and Associated with Low-Grade Inflammation and Obesity-Related Parameters
por: Suárez-Álvarez, K., et al.
Publicado: (2013)

Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity
por: Meyer, Lauren K, et al.
Publicado: (2013)

IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women
por: Lewitt, Moira S, et al.
Publicado: (2010)

Effect of Physical Activity and Obesity on Type 2 Diabetes in a Middle-Aged Population
por: Ansari, Rashid M.
Publicado: (2009)

Plasma 25-Hydroxyvitamin D Is Independently Associated with Hemoglobin Concentration in Male Subjects with Type 2 Diabetes Mellitus
por: Meguro, Shu, et al.
Publicado: (2011)

Systemic Inflammation and Lung Function Impairment in Morbidly Obese Subjects with the Metabolic Syndrome
por: van Huisstede, Astrid, et al.
Publicado: (2013)

Efficacy of an Anthocyanin and Prebiotic Blend on Intestinal Environment in Obese Male and Female Subjects
por: Hester, Shelly N., et al.
Publicado: (2018)

The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
por: Wu, Chen-Ning, et al.
Publicado: (2020)

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus
por: Ou, Yu-Lun, et al.
Publicado: (2021)

Factors Associated with the Decline of Kidney Function Differ among eGFR Strata in Subjects with Type 2 Diabetes Mellitus
por: Meguro, Shu, et al.
Publicado: (2012)

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
por: Chamarthi, Bindu, et al.
Publicado: (2015)

Portable Gentle Jogger Improves Glycemic Indices in Type 2 Diabetic and Healthy Subjects Living at Home: A Pilot Study
por: Adams, Jose A., et al.
Publicado: (2020)

Effects of a Meal Replacement on Body Composition and Metabolic Parameters among Subjects with Overweight or Obesity
por: Guo, Xiaohui, et al.
Publicado: (2018)

Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes
por: Ciaraldi, Theodore P., et al.
Publicado: (2016)

Oxidative Stress Regulates Adipocyte Apolipoprotein E and Suppresses Its Expression in Obesity
por: Espiritu, Doris Joy, et al.
Publicado: (2008)

Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure
por: Sharma, D. C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_22p3irilq1g8niqshishf2qchs